Daniel Tassé
Directeur Général chez DBV TECHNOLOGIES
Fortune : 71 078 $ au 30/04/2024
Profil
Daniel Tassé is currently the Chief Executive Officer & Executive Director at DBV Technologies SA since 2019.
He is also a Director at BioQ Pharma, Inc. and an Independent Non-Executive Director at REGENXBIO, Inc. Additionally, he serves as a Director at Roundtable On Critical Care Policy.
In his former positions, Mr. Tassé served as the Chairman, President & Chief Executive Officer at Ikaria, Inc. from 2009 to 2015.
He was also the Chairman & Chief Executive Officer at Alcresta Therapeutics, Inc. from 2016 to 2018.
Furthermore, he held the position of Director at Biotechnology Innovation Organization from 2011 to 2015 and at Bellerophon Therapeutics, Inc. from 2014 to 2019.
He was the Senior Independent Director at Indivior PLC from 2020 to 2021.
Mr. Tassé also worked as the Vice President & Regional Director-Australasia at GSK Plc from 2004 to 2004 and as the GM-Pharmaceuticals & Technologies Business Unit at Baxter International, Inc. from 2008 to 2008.
He served as a Director at Pharmaceutical Research & Manufacturers of America from 2011 to 2015 and as an Independent Director at HLS Therapeutics, Inc. from 2018 to 2019.
Additionally, he held positions at Healthcare Leadership Council and NRG Energy Ltd.Mr. Tassé completed his undergraduate degree at the University of Montréal.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REGENXBIO, INC.
0,01% | 01/04/2024 | 3 010 ( 0,01% ) | 48 341 $ | 30/04/2024 |
DBV TECHNOLOGIES SA
0,02% | 08/03/2024 | 17 094 ( 0,02% ) | 22 738 $ | 30/04/2024 |
Postes actifs de Daniel Tassé
| Sociétés | Poste | Début |
|---|---|---|
| REGENXBIO INC. | Directeur/Membre du Conseil | 15/08/2016 |
| DBV TECHNOLOGIES | Directeur Général | 29/11/2018 |
BioQ Pharma, Inc.
 BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/12/2014 |
| Roundtable On Critical Care Policy | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Tassé
| Sociétés | Poste | Fin |
|---|---|---|
| INDIVIOR PLC | Président | 19/11/2020 |
| BELLEROPHON THERAPEUTICS, INC. | Directeur Général | 01/06/2014 |
| HLS THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/03/2019 |
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Directeur Général | 01/11/2018 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | 01/06/2015 |
Formation de Daniel Tassé
| University of Montréal | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| REGENXBIO INC. | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| INDIVIOR PLC | Health Technology |
| GSK PLC | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
BioQ Pharma, Inc.
BioQ Pharma, Inc. Pharmaceuticals: MajorHealth Technology BioQ Pharma, Inc. engages in the design and development of a drug delivery systems to administer infusible drugs. It offers Ropivacaine ReadyfusOR and Invenious for manufacturers. The company was founded by Joshua Wilker Kriesel in 2003 and is headquartered in San Francisco, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
Healthcare Leadership Council
 Healthcare Leadership Council Medical/Nursing ServicesHealth Services Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC. | Health Services |
| NRG Energy Ltd. | |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
| Roundtable On Critical Care Policy |
